Add Company
Join Now

Kevin Kendall Email

VP, Market Access Field and Field Sales . Sage Therapeutics

Cambridge, MA

Location

How to contact Kevin Kendall

Join and see Kevin's contact info for free!

Email

Current Roles

Sage Therapeutics

Employees:
768
Revenue:
$97.7M
About
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage's lead product candidate, ZULRESSO(TM) (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.
Sage Therapeutics Address
215 First Street
Cambridge, MA
United States

Past Companies

Sage TherapeuticsVice President, Market Access Field and Field Sales
Sage TherapeuticsVice President, Market Access, Payer and Institutional Acct. Mgmt.
Sage TherapeuticsHead, National and Regional Account Management
www.growjo.com

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.